188 filings
Page 7 of 10
SC 13D
FiveT Investment Management Ltd
21 Jun 21
Inhibikase Therapeutics / FiveT Investment Management ownership change
12:01pm
8-K
IKT
Inhibikase Therapeutics Inc
21 Jun 21
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
9:23am
424B4
IKT
Inhibikase Therapeutics Inc
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
IKT
Inhibikase Therapeutics Inc
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
EFFECT
IKT
Inhibikase Therapeutics Inc
16 Jun 21
Notice of effectiveness
12:15am
S-1
IKT
Inhibikase Therapeutics Inc
IPO registration
11 Jun 21
4:24pm
CORRESP
IKT
Inhibikase Therapeutics Inc
11 Jun 21
Correspondence with SEC
12:00am
CORRESP
IKT
Inhibikase Therapeutics Inc
11 Jun 21
Correspondence with SEC
12:00am
UPLOAD
IKT
Inhibikase Therapeutics Inc
3 Jun 21
Letter from SEC
12:00am
DRS
IKT
Inhibikase Therapeutics Inc
2 Jun 21
Draft registration statement
12:00am
8-K
IKT
Inhibikase Therapeutics Inc
1 Jun 21
Regulation FD Disclosure
7:30am
4
Milton H. Werner
18 May 21
Inhibikase Therapeutics / Milton H. Werner ownership change
5:46pm
10-Q
2021 Q1
IKT
Inhibikase Therapeutics Inc
17 May 21
Quarterly report
4:41pm
DEFA14A
IKT
Inhibikase Therapeutics Inc
30 Apr 21
Additional proxy soliciting materials
5:21pm
DEF 14A
IKT
Inhibikase Therapeutics Inc
30 Apr 21
Definitive proxy
5:20pm
8-K
IKT
Inhibikase Therapeutics Inc
1 Apr 21
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
1:13pm
10-K
2020 FY
IKT
Inhibikase Therapeutics Inc
31 Mar 21
Annual report
2:14pm
SC 13G
Daniel Kalman
23 Mar 21
Inhibikase Therapeutics / Kalman Daniel ownership change
1:32pm
SC 13G
Milton H. Werner
11 Feb 21
Inhibikase Therapeutics / Werner Milton H. ownership change
4:06pm
8-K
IKT
Inhibikase Therapeutics Inc
8 Feb 21
Therapies in Clinical Development to Reverse the Progression of Neurodegeneration in Parkinson’s Disease 1Q 2021 I NVESTOR PRESENTATION IKT
7:01am